Skip to content

Effect of IONM on Efficacy and Safety Using Sugammadex in Thyroid Surgery

Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Increase for Efficiency of Intraoperative Neural Monitoring in the Thyroid Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03634956
Enrollment
2
Registered
2018-08-17
Start date
2018-08-14
Completion date
2019-03-14
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Laryngeal Nerve, Vocal Cord Paralysis

Keywords

multinoduler goitre, thyroid cancer, sugammadex sodium, intraoperative nerve monitorization

Brief summary

Thyroidectomy is a frequently performed surgeon by the head and neck and endocrine surgeons. In recent years, surgical techniques and technological developments have resulted in a significant reduction in complication rates. Despite these advances, there is still a great deal of anxiety about the sound problems that can be experienced in patients after surgery. In the past years,the investigators have tried to prevent recurrent nerve paralysis by using intraoperative nerve monitoring (IONM). The use of IONM has begun to be preferred by many surgeons in the investigator's country. However, the use of IONM decreases the number of recurrent nerve paralysis are still being discussed and many studies have been done. In this study, it is aimed to prevent the formation of recurrent nerve paralysis in order to safely carry out the IONM by removing the effects of neuromuscular blockade drugs using sugammadex sodium medicine in the thyroidectomy operations.

Detailed description

Patients who will undergo thyroidectomy using the IONM in the General Surgery Clinic of Istanbul, Bakırköy Dr.Sadi Konuk Training and Research Hospital. In this prospective observational clinical trial, the patients will be divided into two groups and the study will be performed as randomize. Randomization Patients who arrive consecutively, will be included in the study group (Group I IONM, group B IONM-sugammadex sodium). In both groups, anesthesia induction should be done with 3 mg / kg propofol, 2 ugr / kg fentanyl, 0.6 mg / kg rocuronium bromide, as the intubation tube, the number appropriate for the patient, After reaching the throat loom, the patient is entrapped and then the operation is started. After reaching the thyroid loin and hanging the throid with the swab sutures, the lobe is taken out with the finger maneuver and then the vascular nerve packet is dissected and the vagal nerve is exposed. IONM(Medtronic-NIM) were detected in the recurrent nerve thyroglossal groove and 100 microvolts or more were measured with nerve monitoring. + Acceptance of resection was started and IONM After the intubation of the group B-sugammadex sodium was started, the left hand ulnar sinus TOF-Guard device was placed and operation started. After reaching the thyroid loops and hanging the throids with hanging sutures and removing the lobe with finger maneuver, the vascular nerve was disassembled and the vagal nerve was dislocated. Then the electrical value was recorded with IONM and sugammadex sodium 2 mg / kg was made. and the TOF response at 4th minute is over 90% of the value to be measured and if the IONM is 100 microvolts higher, the recurrent nerve is found in the troglossal groove and the nerve is followed with the IONM and the resection procedure is started and the tirodidectomy will be performed. V0: vagal nerve initial value; V1: value before troid resection; V2: value after troid resection; R1: value after troid resection, R2: value after troid resection. Preoperative and postoperative vocal cord examination will be examined by otolaryngologist. Size, weight, sex, ASA scores, operation times, complications will be recorded. If there is no signal in RLN with intraoperative IONM and RLN paralysis will be accepted if there is inactivity in the vocal cord at the 1st postoperative ENT specialist vocal cord examinations. RLN paralysis will be accepted if there is inactivity in the cord at the vocal cord examination of the postoperative specialist ENT specialist. The ENT specialist and general surgeon will follow up and if the vocal cord is still in motion, the permanent RLN will be considered a paralysis.

Interventions

DRUGGroup B. Sugammadex sodium-IONM

Group B.the vagal nerve is detected and then 2 mg / kg of sugammadex sodium is administered to remove the muscle relaxant effect

Sponsors

Lütfiye Nuri Burat Government Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Group A. Sugammadex sodium-IONM in thyroid surgery Group B.Standart technique-IONM in thyroid surgery

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Multinodular goiter, * Clinical diagnosis of thyroid cancer * Clinical diagnosis of noduler goatr, * Clinical diagnosis of basedow Graves disease,

Exclusion criteria

* Patients with bleeding diathesis, * Patients who have previously undergone laryngeal surgery (vocal polyps, nodules or laryngeal cancer),

Design outcomes

Primary

MeasureTime frameDescription
Vocal cord paralysispostop 15th dayspostoperative vocal cord examination will be performed and the recurrent laryngeal nerve will be examined.

Secondary

MeasureTime frameDescription
vagal nerve conduction value(V1)15 to 45 minutes of surgeryV1: value to receive enough nerve conduction for IONM use from the vagus nerve
vagal nerve conduction value after lob resection(V2)30 to 90 minutes of surgeryV2:Vagus value after resection of thyroid lobe
first detected vagal nerve conduction value(V0)5 to 25 minutes of surgeryinitial value after vagus sinus is detected
TOF time10 to 90 minutes of surgerythe time that the muscle relaxant is shown by the peripheral nerve stimulator whose effect has disappeared.TOF\>0.9

Countries

Turkey (Türkiye)

Contacts

Primary ContactTurgut Donmez, surgeon
surgeont73@hotmail.com+905347400967
Backup ContactMehmet Emin Gunes, surgeon
memgunes@hotmail.com+90532 59943334

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026